As we address various healthcare industry-related issues in 2024, and it being an election year, a whole array of political ramifications exist. So is the ACA on life support, or are we headed toward a reimbursement system that emphasizes quality instead of volume?
No takes yet. Share an insight, caveat, or question.
Max Reiboldt (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: